|
1
|
擴增Mepolizumab 成分藥品(如Nucala)給付範圍
|
|
|
2
|
Atotine oral Solution 4mg/mL “Kojar”
|
|
|
3
|
癌思停注射劑(Avastin Injection) (非小細胞肺癌)
|
|
|
4
|
Jakavi
|
|
|
5
|
Otezla Film-coated Tablets 30mg、20mg、10mg
|
|
|
6
|
薩溫珂凍晶注射劑 (Sylvant)
|
|
|
7
|
戴克癲膠囊250 毫克 /戴克癲口服懸液粉劑250 毫克 (Diacomit Hard Capsules 250mg / Diacomit 250mg powder for oral suspension in sachet)
|
|
|
8
|
莫帕滋膜衣錠、莫帕滋長效注射劑、瑞卡必持續性藥效注射懸浮劑 (Vocabria、Rekambys)
|
|
|
9
|
Takhzyro solution for injection
|
|
|
10
|
拓達維注射劑 (TRODELVY for Injection)
|
|
